Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
CarParts.com announced several changes to its Board committees, including the appointment of Warren Phelps, III as Chair of the Nominating and Corporate Governance Committee. Tim Nauss was appointed to both the Audit and Nominating committees, while Nanxi Liu and Dr. Lisa Costa stepped down from their roles on the Nominating and Corporate Governance Committee.
CorMedix reported Q3 2026 consolidated revenue of $54.5 million and a net loss of $14.7 million, while maintaining its full-year 2026 revenue guidance. The company also highlighted its pending acquisition of Heron Therapeutics assets and a new $150 million term loan facility to support the transaction and operations.
Term
Q3 2026
“CorMedix will be entering 2027 with two meaningful potential growth drivers. First, our pending acquisition of the Heron assets adds four commercial products used in institutional settings of care and is expected to be immediately accretive to earnings and free cash flow upon closing.”
Joseph Todisco, Chairman & Chief Executive Officer
Skye Bioscience received a unanimous jury verdict in its favor following a retrial in the U.S. District Court for the Central District of California. The lawsuit, filed by a former employee, alleged whistleblower protection violations and retaliation related to events occurring between 2018 and 2019. The verdict clears the company of all claims, though the plaintiff retains the right to file post-trial motions or appeals.
MBX Biosciences Chairman, President and CEO Steven L. Hoerter Sells $268K of Stock
Steven L. Hoerter, Chairman, President and CEO, sold 4,893 shares of MBX Biosciences, Inc. at $54.82 a share, worth $268K in total on Nov 10, 2026. Shares held after the trade: 78,045 (-5.9%).
Iron Horse Acquisition II M&A Deal with Electra Vehicles, Inc.
Iron Horse Acquisition II Corp. (IRHO) and its merger target Electra Vehicles, Inc. (ELECTRA AI) announced a three-year partnership where Electra will serve as the Official Battery Intelligence Partner for Westbrook Racing at the E1 Miami GP. This update provides a strategic and marketing milestone for the companies as they work toward completing their previously announced business combination agreement dated April 21, 2026.
Charlotte's Web Holdings reported a net loss of $20.7 million for the nine months ended September 30, 2026, compared to $18.3 million in the prior year. Revenue decreased to $31.4 million from $36.6 million, while the company significantly improved its balance sheet by converting $50.8 million in convertible debentures into common shares.
Orion Group Holdings appointed retired U.S. Navy Rear Admiral Mark A. Handley to its Board of Directors, effective November 11, 2026. Mr. Handley, who previously held senior leadership roles at AECOM, will serve on the Audit, Compensation, and Nominating and Governance Committees. His appointment expands the company's board from six to seven directors.
Apollo Global Management's subsidiary, Athene Holding Ltd., is hosting a Fixed Income Investor call on November 12, 2026. The company has made a formal investor presentation available on its website to provide updates on business trends, new business origination, and its investment portfolio.
LASE Corp. reported a net loss of $8.57 million for the nine months ended September 30, 2026, compared to a loss of $8.11 million in the prior year period. Total assets increased significantly to $15.81 million from $9.45 million at year-end 2025, primarily driven by a substantial increase in current assets following multiple public offerings and warrant inducement exercises.
AllianceBernstein L.P. reported preliminary assets under management (AUM) of $901 billion as of October 31, 2026, a slight increase from $900 billion at the end of September. The growth was primarily driven by market appreciation, which was partially offset by net outflows in the Retail and Institutional channels.
Labcorp Holdings EVP, Pres of BLS, CMO & CSO Brian J. Caveney Sells $744K of Stock
Brian J. Caveney, EVP, Pres of BLS, CMO & CSO, sold 2,000 shares of Labcorp Holdings Inc. at $372.04 a share, worth $744K in total on Nov 10, 2026. Shares held after the trade: 34,562 (-5.5%).
First Watch Restaurant Group Investor Presentation
First Watch Restaurant Group is hosting its inaugural Investor Day in Boston to share its strategic growth vision and long-term financial targets through 2028. The company outlined a path to over 2,200 restaurants and expects to generate positive free cash flow beginning in 2027 to self-fund organic growth.
“Our strategy combines the strength of our leadership in Daytime Dining with substantial whitespace for restaurant growth and an increasingly powerful cash flow model. We see a clear path to more than 2,200 restaurants across the continental U.S. while, beginning next year, we expect our robust cash flow to self-fund organic growth and maintenance capital expenditures and accelerate free cash flow generation.”
Chris Tomasso, CEO and President of First Watch
“Our annual growth targets through 2028 strike an optimized balance between new unit growth and free cash flow. We are on track to open 62 systemwide restaurants in 2026 and approximately 55 in 2027, retaining flexibility on annual openings in the following years.”
Latch, Inc. (DOOR) reported Q3 2026 results featuring 18% software revenue growth and significant gross margin expansion to 55.2%. While total revenue declined 18.9% to $14.1 million due to lower hardware volume, the company improved its Adjusted EBITDA loss and launched its OpenDOOR developer platform.
Term
Q3 2026
“The third quarter results reflect our continued focus on driving profitability, highlighted by our improvement in gross margin. Our priorities are clear: strengthen our best-in-class integrated hardware and software platform, streamline operations, and build a more profitable and sustainable company.”
David Lillis, Chief Executive Officer
“We are leaning into what we do best and exiting non-core operations to focus our resources on higher-margin offerings. The restructuring plan we announced in August, which is expected to reduce annualized operating costs by $10 million to $12 million, is progressing as planned and should accelerate our path to profitability.”
Athene Holding Ltd. has made available a formal presentation titled 'Athene Fixed Income Investor Presentation November 2026' in connection with a fixed income investor call. The presentation was published on the company's investor relations website on November 12, 2026.
Hydrofarm Holdings Group Nasdaq/NYSE Compliance Notice
Hydrofarm Holdings Group, Inc. has regained compliance with Nasdaq's $2.5 million minimum stockholders’ equity requirement following a financial restructuring that eliminated $109 million in debt. The company remains subject to a Mandatory Panel Monitor for one year, during which any failure to satisfy the equity rule would result in an immediate delist notice without the opportunity to submit a new compliance plan.
Counterparty
Nasdaq
Term
through November 9, 2027
“We received notice from Nasdaq that we are in compliance on our stockholders’ equity, another milestone in our financial restructuring. With this confirmation, our organization is focused on profitable growth: our proprietary brands out of Eugene, the direct commercial sales channel that opened when the term loan was eliminated, and scaling logistics services under Project Agility. That’s where our 50th year starts.”
AllianceBernstein reported preliminary assets under management (AUM) of $901 billion as of October 31, 2026, a slight increase from $900 billion at the end of September. The growth was primarily driven by market appreciation, which was partially offset by net outflows in the Retail and Institutional channels.
Sagimet Biosciences reported third quarter 2026 financial results and provided a corporate update on its Phase 3 AURORA clinical trial for denifanstat in moderate to severe acne. The company highlighted a pro forma cash position of $356 million following a $115 million equity financing in October, which is expected to fund operations through mid-2029.
“Building on the positive Phase 3 results from our license partner Ascletis, we have initiated our pivotal U.S. AURORA Phase 3 clinical trial. With our October equity financing, we are well positioned to fund our programs through mid-2029, including the anticipated Phase 3 denifanstat data readout and the potential submission of an NDA.”
ERock reported its first profitable quarter as a public company for Q3 2026, with revenue growing nearly 4x quarter-over-quarter to $152.8 million. The company achieved positive net income of $8.9 million and reaffirmed its full-year 2026 revenue guidance of $435 million to $465 million.
Term
Q3 2026
“We executed well in the third quarter, with record production and deliveries that drove record quarterly revenue and profitability. We began construction at the El Paso Electric facility for Meta, and that project remains on track for completion in mid-2027. We are expanding our manufacturing capacity by 900 MW per year with a new facility in Houston (Atlas). When complete, our total capacity is expected to reach 2.1 GW per year to serve the strong demand for our product. Since the end of the quarter, we added new bookings of more than $300 million, setting a new backlog record and providing revenue and margin visibility into 2028. Our differentiated product and service offerings continue to resonate with customers, and we remain focused on disciplined expansion to meet their needs.”
John Carrington, Chief Executive Officer of ERock
“The third quarter marked an inflection point with revenue growing nearly 4x quarter-over-quarter, driving our first profitable quarter as a public company. We reported $8.9 million of net income and $12.6 million of Adjusted EBITDA. This reflected an improvement of $76.6 million of net income and $26.6 million of Adjusted EBITDA, demonstrating the operating leverage embedded in our business. We expect continued revenue and profitability growth in the fourth quarter and are reaffirming our 2026 guidance. Our robust balance sheet and strong liquidity, coupled with our backlog and unique products and services, give us confidence to expand our manufacturing capacity to meet strong customer demand.”
Audiocodes President and CEO Shabtai Adlersberg Buys $143K of Stock
Shabtai Adlersberg, President and CEO, bought 17,000 shares of Audiocodes Ltd at $8.38 to $8.67 a share (average $8.44) in 3 transactions, worth $143K in total between Nov 9, 2026 and Nov 11, 2026. Shares held after the trade: 4,985,192 (+0.0%).
Go Go Buyers, Inc. reported zero revenue for the nine months ended September 30, 2026, compared to $43,724 in the prior year period. The company incurred a net loss of $56,080 for the first nine months of 2026 and expressed substantial doubt about its ability to continue as a going concern due to a lack of stabilized revenue.
DPC Holdings PLC reported a significant revenue increase to $308.1 million for the quarter ended September 27, 2026, and achieved a net income of $31.8 million compared to a net loss in the prior year period. The company successfully completed an initial public offering during the nine-month period, resulting in a substantial improvement in its equity position and a reduction in total liabilities from $1,859.0 million to $529.5 million.
Lamb Weston, Inc., a subsidiary of Lamb Weston Holdings, Inc., entered into a $25 million settlement agreement to resolve a putative class action lawsuit regarding groundwater nitrate levels in Oregon. The settlement fund will provide property enhancements and water filtration systems for residents, with payment expected in the second half of fiscal year 2027 subject to court approval.
Counterparty
Private plaintiffs in the U.S. District Court for the District of Oregon
For the quarter ended September 30, 2026, Latch, Inc. reported total revenue of $14.1 million, a decrease from $17.4 million in the prior year period. The company recognized a significant $13.6 million goodwill impairment charge, contributing to a net loss of $20.5 million compared to a $6.6 million loss in the same quarter of 2025.
Enovix reported Q3 2026 financial results with revenue of $11.0 million, a 38% increase year-over-year, driven by strong demand in the drone and defense sectors. The company achieved a record non-GAAP gross margin of 34.5% and issued new 2027 revenue guidance of $65 million to $85 million.
“The 100,000-battery order and the first MX1-B01 production order reflect our ability to convert our pipeline into orders. The MX1-B01 has now been sampled by more than 30 industry-leading aerial drone accounts with very positive feedback.”
Steve Bakos, newly appointed Chief Revenue Officer and General Manager of Enovix
News Corporation provided a daily update on its $1 billion stock repurchase program as required by Australian Securities Exchange (ASX) rules. The company is authorized to repurchase both Class A and Class B common stock in the open market from time to time. The filing includes specific daily transaction notifications for Class A common stock repurchases conducted on the Nasdaq.
Solo Brands, Inc. reported a significant increase in cash and cash equivalents to $40.2 million as of September 30, 2026, compared to $20.0 million at year-end 2025. However, total assets decreased from $360.3 million to $322.8 million, driven by lower inventory levels and accounts receivable, while the company continues to manage a substantial long-term debt load of $249.8 million.
Taysha Gene Therapies reported third quarter 2026 financial results and provided a corporate update on its TSHA-102 gene therapy program for Rett syndrome. The company completed its BLA-enabling manufacturing campaign and expects to report topline 6-month interim data and receive FDA feedback on its BLA submission pathway in the first half of 2027.
“During the third quarter, we continued to make strong progress across our clinical, manufacturing and commercial readiness activities as we advance toward a potential BLA submission for TSHA-102. With all patients dosed and having cleared the acute post-dosing safety monitoring period in our REVEAL pivotal and ASPIRE trials with no severe treatment-related serious adverse events or dose-limiting toxicities observed across all studies, our focus now turns to delivering a robust dataset to support our planned BLA submission and further establish the potential of TSHA-102 to address the significant unmet need in Rett syndrome.”
Sean P. Nolan, Chairman and Chief Executive Officer of Taysha
Falcon’s Beyond Global reported Q3 2026 consolidated revenue of $7.3 million, an 80% increase year-over-year, driven by attraction and creative services. The company narrowed its consolidated net loss to $7.7 million and reported a contracted pipeline of $28.0 million for its Attractions and Creative divisions.
Term
Q3 2026
“Our third-quarter results demonstrate continued progress in our growth strategy as we move from building pipeline to executing and delivering major projects. The VAI project announced earlier this year is now underway, bringing together the integrated capabilities of Falcon's Creative and Falcon's Attractions to work across creative design, engineering and attraction delivery.”
Cecil D. Magpuri, Chief Executive Officer of Falcon’s Beyond
Capstone Holding Corp. reported Q3 2026 revenue of $20.0 million, a 46% year-over-year increase, and achieved operating income of $0.4 million. The company updated its full-year 2026 revenue guidance to $70 million, citing higher interest rates slowing housing activity, while noting that its organic sales growth continues to outperform the broader market.
Term
Q3 2026
“We grew revenue 46% and generated income from operations in a difficult housing market. Each of our operating businesses has outperformed its respective market this year, with growth accelerating in the third quarter.”
Solo Brands reported third quarter 2026 net sales of $43.7 million, a 17.6% decrease year-over-year, alongside a net loss of $20.8 million. Despite the revenue decline, the company improved its Adjusted EBITDA margin and generated $6 million in operating cash flow through disciplined cost management and reduced promotional activity.
Term
Q3 2026
“While the third quarter is typically our seasonally smallest sales quarter, we continued to make measurable progress strengthening the business. We improved segment profitability, generated more than $6 million of operating cash flow, and further advanced our transformation strategy through disciplined execution, cost management, and operational efficiency initiatives.”
John Larson, President and Chief Executive Officer
“While revenue performance remains below our expectations, we are encouraged by improving consumer engagement and the strong response to recent product innovation. Products launched over the past year for our Solo Stove segment represented nearly half of our website sales during the quarter, highlighting the strength of our innovation pipeline and the value of our brand portfolio.”
John Larson, President and Chief Executive Officer